150 related articles for article (PubMed ID: 38668048)
21. Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.
Sim Y; Tan VKM; Sidek NAB; Chia DKA; Tan BKT; Madhukumar P; Yong WS; Wong CY; Ong KW
ANZ J Surg; 2018 Oct; 88(10):982-987. PubMed ID: 30141242
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of supplementary ultrasound surveillance in the detection of a second breast cancer in patients with ductal carcinoma in situ.
Almalki HS; Lim A; Allen JC; Teo SY; Lim GH
Clin Breast Cancer; 2021 Dec; 21(6):521-525. PubMed ID: 34544658
[TBL] [Abstract][Full Text] [Related]
23. BILATERAL BREAST CANCER: DIAGNOSIS AND PROGNOSIS.
Ursaru M; Jari I; Gheorghe L; Naum AG; Scripcariu V; Negru D
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):316-20. PubMed ID: 27483711
[TBL] [Abstract][Full Text] [Related]
24. The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer.
Takahashi H; Watanabe K; Takahashi M; Taguchi K; Sasaki F; Todo S
Breast Cancer; 2005; 12(3):196-202. PubMed ID: 16110289
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathological features and prognosis of synchronous bilateral breast cancers].
Niu YR; Wu HW; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):435-440. PubMed ID: 32392926
[No Abstract] [Full Text] [Related]
26. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
27. Bilateral breast cancer.
Gogas J; Markopoulos C; Skandalakis P; Gogas H
Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer.
Shi YX; Xia Q; Peng RJ; Yuan ZY; Wang SS; An X; Cao Y; Tan YT; Jin Y; Cai XY; Sun YL; Teng XY; Liu DG; Jiang WQ
J Cancer Res Clin Oncol; 2012 Apr; 138(4):705-14. PubMed ID: 22237454
[TBL] [Abstract][Full Text] [Related]
29. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics.
Kheirelseid EA; Jumustafa H; Miller N; Curran C; Sweeney K; Malone C; McLaughlin R; Newell J; Kerin MJ
Breast Cancer Res Treat; 2011 Feb; 126(1):131-40. PubMed ID: 20665107
[TBL] [Abstract][Full Text] [Related]
30. Breast-Conserving Surgery in Bilateral Breast Cancer.
O'Brien JA; Ho A; Wright GP; Stempel M; Patil S; Krause K; Morrow M; Gemignani ML
Ann Surg Oncol; 2015 Oct; 22(10):3389-96. PubMed ID: 26265365
[TBL] [Abstract][Full Text] [Related]
31. Lobular carcinoma in situ: observation without surgery as an appropriate therapy.
Carson W; Sanchez-Forgach E; Stomper P; Penetrante R; Tsangaris TN; Edge SB
Ann Surg Oncol; 1994 Mar; 1(2):141-6. PubMed ID: 7834439
[TBL] [Abstract][Full Text] [Related]
32. Synchronous Bilateral Breast Cancers.
Padmanabhan N; Subramanyan A; Radhakrishna S
J Clin Diagn Res; 2015 Sep; 9(9):XC05-XC08. PubMed ID: 26500995
[TBL] [Abstract][Full Text] [Related]
33. Contralateral breast cancer: factors associated with stage and size at presentation.
Mertens WC; Hilbert V; Makari-Judson G
Breast J; 2004; 10(4):304-12. PubMed ID: 15239788
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of Microinvasive Ductal Carcinoma In Situ Versus Noninvasive and Invasive Breast Cancer.
Strang LR; Sun J; Sun W; Boulware D; Kiluk JV; Lee MC; Khazai L; Laronga C
J Surg Res; 2020 Oct; 254():378-383. PubMed ID: 32535256
[TBL] [Abstract][Full Text] [Related]
35. Contralateral axillary nodal involvement from invasive breast cancer.
Kiluk JV; Prowler V; Lee MC; Khakpour N; Laronga C; Cox CE
Breast; 2014 Jun; 23(3):291-4. PubMed ID: 24709584
[TBL] [Abstract][Full Text] [Related]
36. Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence.
Pinsky RW; Rebner M; Pierce LJ; Ben-David MA; Vicini F; Hunt KA; Helvie MA
AJR Am J Roentgenol; 2007 Jul; 189(1):140-4. PubMed ID: 17579163
[TBL] [Abstract][Full Text] [Related]
37. Bilateral synchronous breast cancer developed as metachronous malignancy after therapy of other primaries.
Kurzyński M; Mituś J; Kołodziej-Rzepa M; Sas-Korczyńska B
Ginekol Pol; 2018; 89(5):235-239. PubMed ID: 30084474
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in bilateral breast cancer.
Engin K
Neoplasma; 1994; 41(6):353-7. PubMed ID: 7870220
[TBL] [Abstract][Full Text] [Related]
39. Surgical management for early-stage bilateral breast cancer patients in China.
Chen JJ; Huang NS; Xue JY; Quan CL; Tan YL; Liu GY; Shao ZM; Wu J
PLoS One; 2015; 10(4):e0122692. PubMed ID: 25874699
[TBL] [Abstract][Full Text] [Related]
40. Synchronous, bilateral breast cancer: prognostic value and incidence.
Jobsen JJ; van der Palen J; Ong F; Meerwaldt JH
Breast; 2003 Apr; 12(2):83-8. PubMed ID: 14659335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
